Variant report
Variant | nsv964315 |
---|---|
Chromosome Location | chr4:132161941-132175043 |
allele | n/a |
Outlinks | Ensembl   UCSC |
- TF binding region (count:0)
- CpG islands (count:0)
- Chromatin interactive region (count:0)
- LncRNA region (count:0)
- Mature miRNA region (count: 0)
- miRNA target sites (count:0)
No data |
No data |
No data |
No data |
No data |
No data |
No data |

No. | Variant name | Chromosome position | Chromatin state | Related regulatory elements | Target genes | Extended variants | Associated traits |
---|---|---|---|---|---|---|---|
1 | rs182325822 | chr4:132167429-132167430 | Enhancers | n/a | n/a | Overlapped CNVs | n/a |
2 | rs28605768 | chr4:132167432-132167433 | Enhancers | n/a | n/a | LD-proxies of rSNPOverlapped rCNV | n/a |
3 | rs79319713 | chr4:132167440-132167441 | Enhancers | n/a | n/a | Overlapped CNVs | n/a |
4 | rs116742051 | chr4:132167459-132167460 | Enhancers | n/a | n/a | Overlapped CNVs | n/a |
5 | rs576418781 | chr4:132167463-132167464 | Enhancers | n/a | n/a | Overlapped CNVs | n/a |
6 | rs7661661 | chr4:132167492-132167493 | Enhancers | n/a | n/a | Overlapped CNVs | n/a |
7 | rs150083107 | chr4:132167494-132167495 | Enhancers | n/a | n/a | Overlapped CNVs | n/a |
8 | rs28501108 | chr4:132167497-132167498 | Enhancers | n/a | n/a | LD-proxies of rSNPOverlapped rCNV | n/a |
9 | rs536275470 | chr4:132167511-132167512 | Enhancers | n/a | n/a | Overlapped CNVs | n/a |
10 | rs138500183 | chr4:132167519-132167520 | Enhancers | n/a | n/a | Overlapped CNVs | n/a |
11 | rs187404841 | chr4:132167528-132167529 | Enhancers | n/a | n/a | Overlapped CNVs | n/a |
12 | rs371257589 | chr4:132167549-132167550 | Enhancers | n/a | n/a | Overlapped CNVs | n/a |
13 | rs538833590 | chr4:132167565-132167566 | Enhancers | n/a | n/a | Overlapped CNVs | n/a |
14 | rs558738660 | chr4:132167605-132167606 | Enhancers | n/a | n/a | Overlapped CNVs | n/a |
15 | rs549104454 | chr4:132167607-132167608 | Enhancers | n/a | n/a | Overlapped CNVs | n/a |
16 | rs75152483 | chr4:132167612-132167613 | Enhancers | n/a | n/a | Overlapped CNVs | n/a |
17 | rs111715008 | chr4:132167671-132167672 | Enhancers | n/a | n/a | Overlapped CNVs | n/a |
18 | rs574718326 | chr4:132167672-132167673 | Enhancers | n/a | n/a | Overlapped CNVs | n/a |
19 | rs182937935 | chr4:132167723-132167724 | Enhancers | n/a | n/a | Overlapped CNVs | n/a |
20 | rs186708579 | chr4:132167730-132167731 | Enhancers | n/a | n/a | Overlapped CNVs | n/a |
21 | rs36073654 | chr4:132167757-132167758 | Enhancers | n/a | n/a | Overlapped CNVs | n/a |
22 | rs141630538 | chr4:132167764-132167765 | Enhancers | n/a | n/a | Overlapped CNVs | n/a |
23 | rs34150207 | chr4:132167771-132167772 | Enhancers | n/a | n/a | Overlapped CNVs | n/a |
24 | rs151030701 | chr4:132169651-132169652 | Enhancers | n/a | n/a | Overlapped CNVs | n/a |
25 | rs555601167 | chr4:132169704-132169705 | Enhancers | n/a | n/a | Overlapped CNVs | n/a |
26 | rs373643147 | chr4:132169716-132169717 | Enhancers | n/a | n/a | Overlapped CNVs | n/a |
27 | rs17051165 | chr4:132169728-132169729 | Enhancers | n/a | n/a | LD-proxies of rSNPOverlapped rCNV | n/a |
28 | rs6855567 | chr4:132169789-132169790 | Enhancers | n/a | n/a | LD-proxies of rSNPOverlapped rCNV | mRNA abundance |
29 | rs200087395 | chr4:132169858-132169859 | Enhancers | n/a | n/a | Overlapped CNVs | n/a |
30 | rs144711973 | chr4:132169862-132169863 | Enhancers | n/a | n/a | Overlapped CNVs | n/a |
31 | rs377438935 | chr4:132169866-132169867 | Enhancers | n/a | n/a | Overlapped CNVs | n/a |
32 | rs142202187 | chr4:132169908-132169909 | Enhancers | n/a | n/a | Overlapped CNVs | n/a |
33 | rs374477749 | chr4:132169909-132169910 | Enhancers | n/a | n/a | Overlapped CNVs | n/a |
34 | rs188083608 | chr4:132169916-132169917 | Enhancers | n/a | n/a | Overlapped CNVs | n/a |
35 | rs554865634 | chr4:132169941-132169942 | Enhancers | n/a | n/a | Overlapped CNVs | n/a |
36 | rs147933290 | chr4:132169943-132169944 | Enhancers | n/a | n/a | Overlapped CNVs | n/a |
37 | rs141704444 | chr4:132169949-132169950 | Enhancers | n/a | n/a | Overlapped CNVs | n/a |
38 | rs561669996 | chr4:132169950-132169951 | Enhancers | n/a | n/a | Overlapped CNVs | n/a |
39 | rs115755640 | chr4:132169968-132169969 | Enhancers | n/a | n/a | Overlapped CNVs | n/a |
40 | rs560806783 | chr4:132169999-132170000 | Enhancers | n/a | n/a | Overlapped CNVs | n/a |
Disease | PMID | Source |
---|---|---|
Acute lymphoblastic leukemia | 22237106 | CNVD |
Glioblastoma multiforme | 21080181 | CNVD |
Esophageal squamous carcinoma | 21637470 | CNVD |
Chordoma | 21602918 | CNVD |
HIV/AIDS | 22032296 | CNVD |
Medulloblastoma | 21979893 | CNVD |
Neuroblastoma | 18923191 | CNVD |
Thoracic aortic aneurysm | 21092924 | CNVD |
Intellectual disability | 22102821 | CNVD |
Breast cancer | 21858162 | CNVD |
Small bowel adenocarcinoma | 21586687 | CNVD |
Gastric cancer | 21586687 | CNVD |
Basal cell lymphoma | 16317097 | CNVD |
Diffuse large b-cell lymphoma | 16317097 | CNVD |
Acute lymphoblastic leukemia | 20067559 | CNVD |
Breast cancer | 17603634 | CNVD |
Esophageal squamous carcinoma | 18350619 | CNVD |
Breast cancer | 16272173 | CNVD |
Colorectal cancer | 19359472 | CNVD |
Malignant mesothelioma | 18160781 | CNVD |
Medulloblastoma | 18056178 | CNVD |
Multiple myeloma | 17077331 | CNVD |
Pleural malignant mesothelioma | 18160781 | CNVD |
Primary mediastinal b-cell lymphoma | 17728785 | CNVD |
Oral squamous cell carcinoma | 17134496 | CNVD |
4q-syndrome | 17576883 | CNVD |
Cancer | 21637783 | CNVD |
Non-syndromic sensorineural hearing loss | 18471307 | CNVD |
Colorectal cancer | 20709793 | CNVD |
Muscular dystrophy | 21149563 | CNVD |
Endometrial cancer | 22040021 | CNVD |
Breast cancer | 21264507 | CNVD |
Glioblastoma multiforme | 19960244 | CNVD |
Glioblastoma multiforme | 17387387 | CNVD |
Hepatocellular carcinoma | 22174799 | CNVD |
Liposarcoma | 21253554 | CNVD |
Oligodendroglial tumors | 17285580 | CNVD |
Cervical cancer | 21062161 | CNVD |
Metanephric adenoma | 20802469 | CNVD |
Breast cancer | 16608533 | CNVD |
Lung cancer | 19208797 | CNVD |
Wilms tumour | 21544195 | CNVD |
Breast cancer | 21785460 | CNVD |
Lung cancer | 18438408 | CNVD |
Cancer | 22429812 | CNVD |
Acute lymphoblastic leukemia | 20435627 | CNVD |
Cancer | 21183584 | CNVD |
primary effusion lymphomas | 17116491 | CNVD |
Splenic marginal zone lymphoma | 21957467 | CNVD |
Breast cancer | 17133270 | CNVD |
High-grade prostatic intraepithelial neoplasia | 16573809 | CNVD |
Endometrioid adenocarcinoma | 16974079 | CNVD |
Congenital anomalies of the kidney and urinary tract | 20505237 | CNVD |
Breast cancer | 17393978 | CNVD |
Esophageal cancer | 21851588 | CNVD |
Colorectal cancer | 16272173 | CNVD |
Testicular germ cell tumor | 18059402 | CNVD |
Ovarian cancer | 22174824 | CNVD |
Neuroblastoma | 21899760 | CNVD |
Renal cell carcinoma | 18194544 | CNVD |
Olfactory neuroblastoma | 18408657 | CNVD |
Hepatocellular carcinoma | 16750200 | CNVD |
Acute myeloid leukemia | 16864856 | CNVD |
Hodgkin''s lymphoma | 18641027 | CNVD |
Hodgkin''s lymphoma | 17606441 | CNVD |
T-cell prolymphocytic leukemia | 19278963 | CNVD |
Colorectal cancer | 20459617 | CNVD |
Lung squamous cell carcinoma | 22363434 | CNVD |
Mental retardation | 17847001 | CNVD |
Myelofibrosis | 22110671 | CNVD |
Autism | 18923514 | CNVD |
Autism | 22241247 | CNVD |
Mental retardation | 17901693 | CNVD |
small cell lung cancer | 20016488 | CNVD |
Anaplastic thyroid cancer | 18753363 | CNVD |
No. | Chromosome Location | Chromatin state | Cell line | Tissue |
---|---|---|---|---|
1 | chr4:132167400-132167800 | Enhancers | Foreskin Melanocyte Primary Cells skin03 | Skin |
2 | chr4:132169600-132170000 | Enhancers | Dnd41 | blood |